{"disease":{"id":"relief-of-occasional-eye-overexertion","name":"relief of occasional eye overexertion"},"drugs":{"marketed":[{"drug_id":"tobacco","indication_name":"Relief of occasional eye overexertion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Tobacco","company_name":"Centre for Addiction and Mental Health","drug_phase":"marketed","molecular_target":"","drug_class":"Nitrate Vasodilator [EPC]","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"cynara-scolymus","indication_name":"Relief of occasional eye overexertion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cynara Scolymus","company_name":"Stefan Fischli","drug_phase":"marketed","molecular_target":"","drug_class":"Nitrate Vasodilator [EPC]","quality_score":15,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}